30 results
DEF 14A
COGT
Cogent Biosciences Inc
30 Apr 19
Definitive proxy
5:25pm
CORPORATE GOVERNANCE
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
PRINCIPAL STOCKHOLDERS
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE … of directors, upon the recommendation of the nominating and corporate governance committee, has nominated Dr. Ferrante for election as a Class I
8-K
COGT
Cogent Biosciences Inc
29 Jul 19
Unum Therapeutics Announces New Appointments to its Board of Directors
7:24am
Officers.
On July 26, 2019, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors (the “Board”) of Unum … determined that each of the New Directors are independent under the listing standards of Nasdaq and the Company’s corporate governance guidelines. Ms
8-K
tk7w3 vsznf9
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-10.1
88o1dda82u0 mosx
26 Oct 20
Cogent Biosciences Appoints
7:13am
8-K
EX-99.1
kqxadr bnh4
12 May 21
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results
7:14am
8-K
EX-3.2
mbgjvg
5 Oct 20
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
9:08am